Christie White/Courtesy photo

ALBUQUERQUE — Lovelace Health System has named Christie White, MBA, HCM-CMPE as the chief operations officer (COO) of Lovelace Medical Group effective April 18, 2022.

Christie has more than 26 years of experience in healthcare, including both inpatient hospital and ambulatory operation management. She most recently served as assistant vice president of hospital operations for Lovelace Medical Group/Lovelace Medical Center/Lovelace Cancer Center. In this role, she managed all aspects of the hospital medicine services and ambulatory services, including the hospitalist program, medical oncology, radiation oncology, gamma-knife, infectious disease, and the neuro-hospitalist program.

Under White’s leadership, Lovelace opened the Monoclonal Antibody Therapy Clinic on a short timeline. To date, the clinic has completed more than 900 treatments. In addition to leading the radiation oncology program to achieve ACR accreditation in 2017 and re-accreditation in 2020, White is preparing the Cancer Program for its 2023 Commission on Cancer (CoC) accreditation.

She received a bachelor of science degree in business administration and an MBA in healthcare management from University of Phoenix. She is a member of the board of directors for the New Mexico Cancer Research Alliance, a member of the Society of Hospital Medicine, Society for Radiation Oncology Administrators and the American Society of Radiation Oncology Administrators.